- Home
- PMN vs TENX Comparison
PMN vs TENX Comparison
Compare PMN & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- TENX
- Stock Information
- Founded
- PMN 2004
- TENX 1967
- Country
- PMN Canada
- TENX United States
- Employees
- PMN N/A
- TENX N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- PMN Health Care
- TENX Health Care
- Exchange
- PMN Nasdaq
- TENX Nasdaq
- Market Cap
- PMN 23.5M
- TENX 27.3M
- IPO Year
- PMN N/A
- TENX N/A
- Fundamental
- Price
- PMN $0.42
- TENX $7.23
- Analyst Decision
- PMN Strong Buy
- TENX Strong Buy
- Analyst Count
- PMN 3
- TENX 3
- Target Price
- PMN $4.33
- TENX $16.67
- AVG Volume (30 Days)
- PMN 819.9K
- TENX 95.1K
- Earning Date
- PMN 11-13-2025
- TENX 11-14-2025
- Dividend Yield
- PMN N/A
- TENX N/A
- EPS Growth
- PMN N/A
- TENX N/A
- EPS
- PMN N/A
- TENX N/A
- Revenue
- PMN N/A
- TENX N/A
- Revenue This Year
- PMN N/A
- TENX N/A
- Revenue Next Year
- PMN N/A
- TENX N/A
- P/E Ratio
- PMN N/A
- TENX N/A
- Revenue Growth
- PMN N/A
- TENX N/A
- 52 Week Low
- PMN $0.38
- TENX $4.30
- 52 Week High
- PMN $1.59
- TENX $8.24
- Technical
- Relative Strength Index (RSI)
- PMN 41.57
- TENX 53.01
- Support Level
- PMN $0.41
- TENX $7.16
- Resistance Level
- PMN $0.48
- TENX $7.75
- Average True Range (ATR)
- PMN 0.04
- TENX 0.50
- MACD
- PMN -0.00
- TENX -0.03
- Stochastic Oscillator
- PMN 5.00
- TENX 59.80
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.